Position in OCUL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$100,793
-$23,817 QoQ
Shares Held
11,900
-30.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bayesian Capital Management, LP holds $2,677,814 across 10 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,700 | $607,734 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
4,300 | $570,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
808 | $503,820 | |
| 4 | GMAB |
Genmab A/S
|
10,369 | $284,836 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,300 | $268,983 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
17,200 | $250,604 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
18,400 | $70,840 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
15,300 | $63,648 |
All Filings in OCUL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,793 | 11,900 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $124,610 | 17,000 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $93,766 | 10,304 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $192,984 | 37,400 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $65,124 | 16,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $69,300 | 14,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||